At the news
? NEUTRALIMPACT 2/10 8-K filed Sep 14, 2026 at 09:26 ET
BioMarin appointed Robert Plenge, M.D., Ph.D., to its Board of Directors, expanding the board from ten to eleven members, and granted him $400,000 in restricted stock units. This is a routine director appointment with no material financial implications for the company.
- Board size increased from ten to eleven members with the appointment of Robert Plenge, M.D., Ph.D., effective September 10, 2026.
- Dr. Plenge was appointed to the Science and Technology Committee.
- He received a restricted stock unit grant valued at $400,000, vesting on the date prior to the next annual meeting.
- No departure of existing directors or C-suite executives is reported.
Before · The news · First close · A day later · A week later
Replay the market's reaction
Step through every 5 minutes around the news, then see how it compares with similar events.
Subscribe for Full Access